The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.
In July, Japanese prosecutors laid charges against the unit over claims** that falsified data was used to exaggerate the benefits of a popular blood-pressure drug.**
They also indicted a former employee, Nobuo Shirahashi, alleging he manipulated the data in clinical studies that were later used in marketing the drug Valsartan.
I think this happens much more than we think it does even in the US.
Birth control pills have been marketing under hundreds of different names to conceal blood clot deaths. Our emergency rooms have dealt with so many cases of potential deaths and these girls were saved by good medical care.